Daily Stock Tips

Amphastar Pharmaceuticals (AMPH) – Nasdaq

Amphastar Pharmaceuticals, amph, nasdaq, stock tips, e-stockquotesAmphastar Pharmaceuticals, founded in 2004, is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of generic, and injectable and inhalation products. The Company produces approximately 15 injectable products.

The Company’s Enoxaparin Sodium Injection is the generic equivalent to Lovenox indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis. Its Cortrosyn (cosyntropin for Injection) is a diagnostic agent used in the screening of patients presumed to have adrenocortocal insufficiency. With Cortrosyn’s rapid effect on the adrenal cortex, it may be utilized to perform a 30-minute test of adrenal function (plasma cortisol response) as an office or outpatient procedure requiring only two venipunctures.

The Lidocaine HCl Jelly, USP, 2% (Preservative Free), URO-Jet is a preservative-free topical local anesthetic agent and is provided in the Uro-Jet prefilled syringe, which is designed to reduce discomfort during the product application. Lidocaine HCl, 4% Topical Solution, USP-Laryng-O-Jet is indicated for the topical anesthesia of the respiratory tract. It is provided in the Laryng-O-Jet prefilled syringe, which is designed to reduce discomfort during product application. Naloxone HCl Injection is indicated for the complete or partial reversal of narcotic depression and diagnosis of suspected acute opioid overdose. Phytonadione Injection (Vitamin K1) for newborns.

Analyst Rating Update on Amphastar Pharmaceuticals, Inc.
Bar and Graph Report - 13 hours ago
As many as 4 brokerage firms have rated Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) at 1.25. Research Analysts at Zacks have ranked the company at 3, suggesting the traders with a rating of hold for the short term.
Amphastar Pharmaceuticals Sets New 1-Year High at $14.70 (AMPH) - Intercooler
Posted: March 6, 2015, 10:18 am
Amphastar Pharmaceuticals Inc (DE) (AMPH) is Trading Higher on Unusual ...
Equities.com - Mar 4, 2015
Amphastar Pharmaceuticals Inc (DE) ($AMPH) experienced unusually high volume on Mar. 04, as the stock gained 3.35% to a closing price of $14.49.
Posted: March 4, 2015, 10:30 pm
Update: Amphastar Pharmaceuticals, Inc. Short Interest Grows by 8.3%
Bar and Graph Report - Mar 2, 2015
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) has witnessed a colossal rise of 8.3% or 40,837 shares in its short figure.
Posted: March 2, 2015, 10:30 pm

Viewing page 1 of 4|Next Page


Please note the Technical Indicators and Fundamental Factors listed below will fluctuate as market prices change.

Technical Indicators:

  • 100% Technical buy signals
  • Trend Spotter by signal
  • Above its 20, 50 and 100 day moving averages
  • 6 new highs and up 12.58% in the last month
  • Relative Strength Index 78.14%
  • Technical support level at 13.67
  • Recently traded at 14.52 with a 50 day moving average of 12.55
Fundamental Factors:
  • Market Cap: $650.9 Million
  • P/E: NA
  • EPS: ($0.14)
  • Dividend: $0.00
  • Dividend Yield: NA
  • Revenue expected to grow by 1.30% next year
  • Earnings estimated to compound at an annual rate of 5.00% for the next 5 years
  • Wall Street analysts issued 3 strong buy and 1 buy recommendation on the stock
The 50-100 Day MACD Oscillator has been an effective technical trading strategy on this stock and should continue to be used for entry and exit points.

e-stockquotes.org © 2014 Frontier Theme